Crossmark

Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis

Crossref DOI link: https://doi.org/10.1038/s41598-019-49129-6

Published Online: 2019-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kopecki, Z. https://orcid.org/0000-0002-8072-4222
Yang, G.

Treloar, S.

Mashtoub, S.

Howarth, G. S.

Cummins, A. G.

Cowin, A. J.
License Information

Text and Data Mining valid from 2019-09-05

Version of Record valid from 2019-09-05
More Information

Article History

Received: 8 April 2019

Accepted: 15 August 2019

First Online: 5 September 2019

Competing Interests

: IP associated with this project has been filed by AbRegen Pty Ltd, of which A.J.C. is a shareholder and both A.J.C. and Z.K. are named inventors on associated patents.

Document is current

Any future updates will be listed below